Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -3.62M | $ -1.42 | 1 | 2.55M |
3/31/2025 | $ -3.88M | $ -1.52 | 1 | 2.55M |
12/31/2024 | $ -5.46M | $ -2.87 | 1 | 1.91M |
9/30/2024 | $ -5.32M | $ -3.8 | 1 | 1.4M |
6/30/2024 | $ -5.55M | $ -4.07 | 1 | 1.36M |
3/31/2024 | $ -5.93M | $ -7.84 | 1 | 756.84K |
12/31/2023 | $ -4.98M | $ -17.89 | 1 | 278.59K |
9/30/2023 | $ -6.39M | $ -22.92 | 1 | 278.59K |
6/30/2023 | $ -6.44M | $ -23.13 | 1 | 278.59K |
3/31/2023 | $ -6.61M | $ -23.73 | 1 | 278.59K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for EVOKE PHARMA INC is calculated as follows: FCF [ $ -6.07M ] / (Shares WA [ 181.57K ] * Share Factor [ 1 ])
(=) FCFPS [ $ -33.41 ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.88 |
average | $ 0.8 |
median | $ 0.3 |
std | $ 2.82 |